Evidence map›Paper›PMID 31924270›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2020

Yanping Jiang, Lijuan Wang, Wenlan Zhou, Jiamei Gu, Ying Tian, Ye Dong, Lilan Fu, Hu-Bing Wu

Open access · goldAbstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Atypical [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Evolution ofDiagnostics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yanping JiangNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Lijuan WangNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Wenlan ZhouNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Jiamei GuNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Ying TianNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Ye DongNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Lilan FuNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China.
Hu-Bing WuNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, Guangdong Province, China. wuhbym@tom.com.
Southern Medical University · CNNanfang Hospital · CN

Funding

Medical Scientific Research Foundation of Guangdong Province A2016590National Natural Science Foundation Project of China 81371591National Natural Science Foundation Project of China 81873905
6 · The paper itself

Abstract

objectiveTo investigate the

methodsFifty patients with ALCL, including 32 anaplastic lymphoma kinase (ALK)-positive patients and 18 ALK-negative patients, were enrolled. The positive detection, maximal standardized uptake value (SUV

resultsALCL lesions were demonstrated to be

conclusionThe present study demonstrated that ALCL is a systemic

Indexed as

Positron Emission Tomography Computed TomographyAdolescentAdultAgedChildChild, PreschoolFemaleFluorodeoxyglucose F18HumansLymphoma, Large-Cell, AnaplasticMaleMiddle AgedRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsAnaplastic large cell lymphoma (ALCL)Anaplastic lymphoma kinase (ALK)Computed tomography (CT)DeoxyglucoseDiffuse large B cell lymphoma (DLBCL)Image featurePositron emission tomography (PET)

Identifiers

PMID31924270
PMCPMC6954597
OpenAlexW3004486068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.